AbCellera Biologics (ABCL) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today 9

3 insiders bought $1.6M. No sales.

BuyMichael R. Hayden$570KDirectorat $10.64 on Aug 24, filed Aug 24

BuyMichael R. HaydenDirector$570Kat $10.64 on Aug 24, filed Aug 24

BuyJohn S. Montalbano$110KDirectorat $11.03 on Aug 18, filed Aug 18

BuyJohn S. MontalbanoDirector$110Kat $11.03 on Aug 18, filed Aug 18

BuyMichael R. Hayden$481KDirectorat $10.37 on Aug 12, filed Aug 14

BuyMichael R. HaydenDirector$481Kat $10.37 on Aug 12, filed Aug 14

From SEC Form 4s, the newest filed Aug 24, 2026 · Insiders have 2 business days to file a trade

2 more filings on ABCL in the last 6 months, for Pro members. See them free →

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 5 tradesSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on ABCL with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at AbCellera Biologics

Insider trades by person

Cluster buys at ABCL

3 insiders bought ABCL in the last 6 months: Michael R. Hayden, Andrew Booth, and John S. Montalbano.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about ABCL's insider trades

As of Nov 2, 2026: AbCellera Biologics (ABCL) has 5 insider filings on record in the last 6 months, the newest filed Aug 24, 2026. Its Quality Score is 9 (Average). Scores as of 5:08 PM ET, 15 minutes behind.

Are ABCL insiders buying or selling?

3 insiders bought $1.6M across 5 filings in the last 6 months. No open-⁠market sales on record. The newest filing: Michael R. Hayden, Director, bought $570K on Aug 24, 2026. 3 insiders bought ABCL in the last 6 months: Michael R. Hayden, Andrew Booth, and John S. Montalbano.

Who are ABCL's biggest insider sellers?

No ABCL insider sold shares on the open market in the last 6 months, as filed on Form 4.

When did an ABCL insider last buy?

Michael R. Hayden, Director, bought ABCL shares ($570K) on Aug 24, 2026, the newest insider buy on record.

AbCellera Biologics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech. ABCL is on insider buys, Aug 24 to 30, 2026.